Abstract:Purpose: Melanocytic nevi are common cutaneous lesions. This study aimed to demonstrate the concordance and discordance between clinical and histopathological diagnoses of melanocytic nevi and the importance of histological evaluation in differentiating malignant lesions from diseases with similar clinical manifestations. Patients and Methods: We studied 4,561 consecutive patients with a clinical diagnosis of melanocytic nevi from 2014 to 2019. We compared the clinical diagnosis with the histopathological diagnosis to establish a histopathological concordance rate and then investigated the effects of clinical characteristics and the reasons for removal on misclassification. Results: Among 4,561 patients who were clinically diagnosed with melanocytic nevi, the overall histopathological concordance rate was 82.11% (3,745 of 4,561 patients), while the histopathological discordance rate was 17.89% (816 of 4,561 patients). The histopathological concordance included 90.25% common acquired melanocytic nevi (3,380 of 3,745 patients) and 9.75% other benign melanocytic neoplasms (365 of 3,745 patients). The most common diagnostic change was to seborrheic keratosis ( n = 470, 10.30%), followed by basal cell carcinoma ( n = 64, 1.40%), vascular tumor ( n = 53, 1.16%), fibroma ( n = 43, 0.94%), epidermoid cyst ( n = 34, 0.75%), wart ( n = 30, 0.66%), melanoma ( n = 24, 0.53%), Bowen's disease ( n = 16, 0.35%), squamous cell carcinoma ( n = 4, 0.09%), keratoacanthoma ( n = 2, 0.04%), and other neoplasms ( n = 76, 1.67%). Male sex, old age, location of the lesion, and the reasons for removal have a potential effect on misclassification. The percentages of misclassified lesions on the trunk and limbs and the perineum and buttocks were higher than those in lesions without a change in diagnosis. Importantly, locations of lesions on the head and neck were significantly related to a change in diagnosis to non-melanoma skin cancer, while locations on the hands and feet were significantly related to a change in diagnosis to melanoma. In addition to a typical clinical features, removal due to lesion changes or repeated stimulation was significantly associated with a change in diagnosis to melanoma. Conclusions: Our study emphasizes the clinical differential diagnosis of melanocytic nevi, especially the possibility of malignant tumors. The occurrence of clinical features associated with clinicopathological discordance should raise the clinical suspect and be carefully differentiated from malignant tumors.

Immunohistochemical Profiling of Conjunctival Melanocytic Intraepithelial Lesions, Including SOX10, HMB45, Ki67, and P16

Conjunctival nevi and melanoma: multiparametric immunohistochemical analysis, including p16, SOX10, HMB45, and Ki-67

Stage-specific prognostic biomarkers in melanoma.

Validation of the Newly Proposed World Health Organization Classification System for Conjunctival Melanocytic Intraepithelial Lesions: A Comparison with the C-MIN and PAM Classification Schemes

HMB-45 May Be a More Sensitive Maker Than S-100 or Melan-A for Immunohistochemical Diagnosis of Primary Oral and Nasal Mucosal Melanomas.

A Multicenter Study Validates the WHO 2022 Classification for Conjunctival Melanocytic Intraepithelial Lesions With Clinical and Prognostic Relevance

Prognostic Factors for Conjunctival Melanoma: a Study in Ethnic Chinese Patients.

Comparison between melanoma gene expression score and fluorescence in situ hybridization for the classification of melanocytic lesions

Genetic analysis of metastatic versus nonmetastatic conjunctival melanoma using a cutaneous melanoma gene expression panel

Clinicopathological, Immunohistochemical and Fluorescence In‐situ Hybridisation Features of Early Subungual Melanoma: an Analysis of 65 Cases

Application of immunocytochemistry and BRAF mutational analysis to direct smears of metastatic melanoma

High-risk histopathologic features in local advanced conjunctival melanoma

American Joint Committee on Cancer Tumor Staging System Predicts the Outcome and Metastasis Pattern in Conjunctival Melanoma

A Clinicopathological Analysis of Melanocytic Nevi: A Retrospective Series

Insights into Melanoma Clinical Practice: A Perspective for Future Research

Microphthalmia transcription factor immunohistochemistry for FNA biopsy of ocular malignant melanoma

Prognostic Value of an Immunohistochemical Signature in Patients With Head and Neck Mucosal Melanoma

SOX11, SOX10 and MITF Gene Interaction: A Possible Diagnostic Tool in Malignant Melanoma

A Comparison of Preferentially Expressed Antigen in Melanoma Immunohistochemistry and Diagnostic Gene Expression-Profiling Assay in Challenging Melanocytic Proliferations

Validation of an Accurate Automated Multiplex Immunofluorescence Method for Immuno-Profiling Melanoma

Intraoperative Immunohistochemistry During Mohs Micrographic Surgery and Staged Excision Decreases Local Recurrence Rates for Invasive Cutaneous Melanoma: A Systematic Review and Meta-Analysis